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Abstract
Recently, deep learning algorithms have been used with success in a variety of do-
mains. Deep learning has proven to be a very helpful tool for discovering complicated
structures in high-dimensional and big datasets. In this work, five deep learning mod-
els inspired by AlexNet, VGG, and GoogleNet are developed to predict mechanism
of actions (MOAs) based on phenotypic screens of a number of cells in dimly lit and
noisy images. We demonstrate that our models can predict the MOA for a com-
pendium of drugs that alter cells through single cell or cell population views without
any segmentation and feature extraction steps. According to these results, our models
do not need to fully realize single-cell measurements to profile samples because they
use the morphology of specific phenomena in the cell population samples.
We used an imbalanced High Content Screening big dataset to predict MOAs with
the main goal of understanding how to work properly with deep learning algorithms on
imbalanced datasets when sampling methods, like Oversampling, Undersampling, and
Synthetic Minority Over-sampling (SMOTE) algorithms are used for balancing the
dataset. Based on our findings, it is now clear that the SMOTE sampling algorithm
must be part of the deep learning algorithms when confronting imbalanced datasets.
High Content Screening technologies have to deal with screening thousands of
cells to provide a number of parameters for each cell, such as nuclear size, nuclear
morphology, DNA replication, etc. The success of High Content Screening (HCS)
systems depends on automatic image analysis. Recently, deep learning algorithms
have overcome object recognition challenges on tasks with a single centered object
per image. Present deep learning algorithms have not been applied to images that
ii
include multiple specific complex objects, such as microscopic images of many objects
such as cells in these images.
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Chapter 1
Introduction
High Content Screening (HCS) is a technology applied in biological studies and drug
discovery to recognize objects such as molecules or RNAi that change the phenotype
of a cell [27, 65].
1.1 Problem Statement
HCS is used for phenotypic screening of cells, see Figure 1.1. Phenotypic variations
sometimes can increase or decrease the size or quantity of cellular components such
as proteins or modify the appearance and morphology of a cell.
Recent microscopy and high performance computing technologies have rapidly
advanced the development of high-throughput image-based techniques. The success
of HCS systems is dependent on automated image analysis. These methods deal
with the screening of thousands of cells to provide a number of parameters for each
cell, such as DNA replication, nuclear size, nuclear morphology, etc. Analyzing this
high-dimensional problem requires machine learning algorithms. We believe that as
these parameters are high dimensional, deep learning algorithms can be useful to help
classify, cluster and visualize cells in High Content Screening applications.
Figure 1.1: High Content Screening system overview
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1.2 The Contribution of this Thesis
Analyzing large amounts of microscopy data is a challenging problem. Cell images
have different features, where most of the cells are characterized by noisy and cluttered
background patterns that make segmentation and automatic recognition of cells very
problematic.
1- Recent microscopy and high performance computing technologies have made
advancement of high throughput screening systems that are used in drug discovery,
biology, and chemistry. Most subtle features such as DNA replication, nuclear size,
and nuclear morphology can be observed in each image precisely by using High Con-
tent Analysis (HCA) methods. To solve this high-dimensional problem, biologists
feed single cell information to machine learning algorithms such as K-nearest neigh-
bors, support vector machines, or random forests. According to a recent study [61],
about 70% of the papers on HCA experiments published in Science, Nature, Cell, and
the Proceedings of the National Academy of Sciences from 2000 to 2012 only used one
or two of the cells measured features and less than 15% used more than six. As a
result, about 85% of the research work in HCA underutilized potentially valuable
information that might have helped to speed up early-stage drug discovery [61]. In
this project, we are interested in exploring cutting-edge machine learning algorithms
developed in the field of deep learning to solve high-dimensional data problems with
thousands of measured features.
2- Recently, deep learning algorithms have overcome object recognition challenges.
These tasks normally have a single centered object per image and current algorithms
have not directly been tested on images with populations of objects (for example, the
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population of cells in microscopy images). Generally, there are a number of objects
such as cells in microscopy images. In this project we provide deep learning models
based on populations of objects (cells) and a single cell view in order to predict MOAs
of drugs without using any segmentation or feature extraction steps.
3- HCS, when formulated as a problem in machine learning, is usually considered
as an object recognition task. Cell images have different characteristics. They are
dimly lit and noisy. The main purpose of this project is to predict a label for each
cell or a population of cells, based on poor lighting and noisy images containing a
single cell or a population of cells.
4- In High Content Screening object identification, the natural biological variation
amongst cell populations mostly provides a variety of phenotypes. This subject makes
some phenotypes difficult to recognize and complicates the labeling task, particularly
phenotypes that have low penetrance.
5- Although image samples provide a number of benefits and details, analyzing
huge amounts of microscopy data is a challenging problem [32, 46]. Manual scoring
of complex patterns and phenotypes such as cell protein localizations is hard and
specialist cell biologists in various groups across the world score images manually,
but variability between experts decrease accuracy [9, 66]. Computational profiling or
classifying phenotypes is a substitute to manual evaluation, as was done by Chong et
al. [17](2015). Most high content screens have only used a handful of parameters from
each sample, not all parameters [17, 61, 62]. HCS needs experts to apply cutting-edge
machine learning algorithms to classify or cluster cellular phenotypes that can not be
assessed manually [1]. It is clear that a High Content Screening system involves large
quantities of image data which makes it really expensive for us to detect and recog-
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nize manually. The generalization ability of traditional methods is restricted when
they encounter images with different spatial information because they rely mostly on
previous knowledge. These algorithms are ineffective for Big Data since they involve
a massive number of operations for estimating the priors. Moreover, traditional clas-
sifiers are impractical for real-time applications since they are slow when used on Big
Data.
To summarize, the contribution of this study will be the provision of a High
Content Screening system by deep learning algorithms to analyze HCS images in
order to solve the aforementioned problems. The focus will be on the challenge of
using as much information content as possible, by considering a population of cells
and single cell information.
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1.3 The Structure of Thesis
The thesis is organized as follows. Chapter 2 outlines related works on machine
learning algorithms used in HCS, drug discovery, and cell biology. In chapter 3,
we review the methodologies. The experimental design and results are described in
chapter 4. Finally, a conclusion chapter is presented.
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Chapter 2
Related Work
High Content Screening (HCS) technologies are used in cell biology, drug discovery,
and biotechnology to recognize small molecules, RNAi, peptides, etc. [27, 65]. Recent
developments in automated fluorescence microscopy systems have opened more doors
to extract valuable phenotypic information from high content imaging screens [11,
20, 46]. The combination of automated fluorescence microscopy and high throughput
technologies has led to experiments designed to infer relationships between genetic
perturbations and cellular phenotypes.
In genomics screens, researchers tend to discover relations between genes by imag-
ing cells with different genetic perturbations such as RNA interference or a genetic
deletion [12, 32, 57]. High Content Screening of drug candidates using in vitro cell
assays has led to more informed drug discovery in pharmaceutical research [42, 51].
Research on drug response screens in mammalian cells [47, 49, 53], protein localiza-
tion in yeast [9, 17, 66], and cell morphology characterization [69, 70] are examples
that utilized these technologies.
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One of the promising works that highlights using imaging in comparison to lower
dimensional features was done by Vizeacoumar et al. [67] that combines High Content
Screening with synthetic genetic arrays to discover 122 additional genes involved in
spindle function that were not recognized previously in a colony fitness based genetic
interaction screen [68].
These High Content Analysis methods deal with screening thousands of cells which
can provide a number of parameters for each cell such as nuclear size, nuclear morphol-
ogy, DNA replication, etc. The success of these systems is dependent on automated
image analysis. Analyzing this high throughput high-dimensional problem requires
machine learning algorithms. Automatically classifying or profiling phenotypes, as
was done by Chong et al. [17](2015), are preferable alternatives to manual assess-
ment. Figure 2.1 shows a traditional work-flow for cellular classification. On the
other hand, learning millions of cells from thousands of images requires a model with
tremendous learning capacity.
In image-based profiling of cellular morphology, Ljosa et al. [47] compared five
profiling algorithms including Means, Kolmogorov-Smirnov (KS) statistic, Normal
Vector to Support-Vector Machine Hyperplanes, Gaussian Mixture Modeling, and
Factor Analysis using the same experimental configuration, which is also tested on
the BBBC021 dataset [10]. After segmenting these images, feature extraction was
performed using CellProfiler software. 453 features in total were extracted per cell
including size, intensity, shape, texture and neighborhood information. The profiles
produced were assessed by classifying each treatment condition into its MOA. The
term mechanism of action (MOA) refers to a sharing of similar phenotypic outcomes
among various compound treatments, rather than referring strictly to modulation of
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a particular target or target class [47]. For assigning each treatment to an MOA, a K-
nearest neighbor classifier was applied. The Factor Analysis method was considered
as the best performing profiling algorithm with a mean accuracy of 94% on just a
small part of the dataset including 10% of all samples and not all the data [47]. Singh
et al.[60] focused on improving accuracy by illumination correction in the images.
Moreover, they realized that the Mean profiles are more robust than Factor Analysis
profiles.
Figure 2.1: A usual work-flow for cellular classification [39]
Recently, deep learning algorithms have overcome object recognition issues. Figure
2.2 shows a deep learning work-flow for cellular classification. Deep learning has
been applied to profiling cells for profile aggregation [72], MOA classification from
CellProfiler features [36] and MOA classification from raw images [39]. Zamparo et
al. used autoencoders for dimensionality reduction to improve the quality of profiles
[72]. Kandaswamy et al. used the 453 features of each cell through CellProfiler
software for a particular MOA class [36], similar to the work of Ljosa [47]. Kraus
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et al. [39] tested their model on raw images in the BBBC021 dataset as applied in
our study and got better results in comparison to traditional methods. This method
locates regions with cells and adds a segmentation step to classify MOAs.
Figure 2.2: Deep Learning work-flow for cellular classification [39]
2.1 Machine Learning
Researchers have to utilize automatic algorithms to classify or cluster cells that they
cannot evaluate manually [1] because HCS experiments deal with millions of cell
images [17, 62]. The two classes of machine learning algorithms applied are supervised
learning and unsupervised learning. In supervised learning a human expert interprets
a subset of cells that map cell features to the appropriate output while unsupervised
learning tries to extract patterns such as clusters of cells with similar phenotypes
10
from unlabeled cells.
2.1.1 Supervised Learning
Supervised learning methods typically try to learn a discriminative decision boundary
through a subset of data tagged manually into various classes. These algorithms learn
to categorize instances by improving their internal variables during the training step
to minimize the error between their predictions and the target labels. During the
testing step, another dataset of labeled data is applied to evaluate the ability of
algorithms to generalize when encountering data not seen during the training step
[6].
Research on protein localization [14, 17], drug profiling [47, 53], and changes in
cell morphology [3, 70] are examples of phenotypes that have been trained through
supervised learning algorithms. Support Vector Machines (SVM) [17, 24, 29, 49],
random forests [37], neural networks [7, 31], and adaptive boosting [35] are supervised
learning algorithms that have been applied to classify cellular phenotypes. Support
Vector Machines attempt to find an optimal hyper plane that classify data points
belonging to different categories [18]. Random forest [8] and adaptive boosting [22]
are ensemble learning algorithms that synthesize multiple weak machine learning
algorithms to provide a strong machine learning algorithm.
Neural networks are made of layers with artificial neurons that improve their
parameters during the training step [55]. Because of recent success in training multi-
layer neural networks, as deep learning algorithms, these algorithms currently reach
innovative performance on many domains.
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2.1.2 Unsupervised Learning
Sometimes a subset of labeled data is not accessible within a dataset, for example
in HCS cases, when phenotype classes are not known in advance or are too subtle
to accurately recognize manually. In such cases, unsupervised learning methods can
be applied to learn patterns within this kind of dataset [26]. These methods tend to
learn the structure of the dataset by finding clusters of data points that are similar.
These strategies try to minimize a distance criterion between data points within the
similar cluster and maximize the distance between data points belonging to various
clusters [6].
One of the most important branches of unsupervised learning is clustering algo-
rithms to include hierarchical clustering, K-means clustering, and Gaussian mixture
models (GMM) that are applied to assemble unlabeled cells. Hierarchical clustering
establishes a tree diagram by considering each data point as a cluster and unifying
clusters recursively through a distance criterion [25]. Hierarchical clustering was ap-
plied to recognize distinct clusters of mRNA localization patterns in a large-scale
fluorescence in situ hybridization (FISH) screen by Battich et al. [4]. Moreover,
affinity propagation is one of the popular clustering algorithms that has been widely
applied on gene expression [38, 45]. This method recognizes data points representa-
tive of clusters as perfect instances through looking at similarities amongst all pairs of
data points [23]. K-means and Gaussian mixture models (GMMs) update repeatedly
the cluster centers and the data points assigned to the nearest cluster center through
the EM (expectation-maximization) algorithm [19].
In drug profiling, Ljosa et al. [47] evaluated various profiling algorithms on a small
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portion of the BBBC21 drug screen dataset [10] and realized that Factor Analysis
algorithm can achieve the best results. Young et al. [71] discovered that compounds
that produce the same phenotypic profiles have the same chemical structures by the
factor analysis method. PCA (Principal Component Analysis) was used to reduce
the feature space and eventually GMMs were applied to measure cellular phenotype
heterogeneity in cancer societies by Singh et al. [59]. Zhong et al. [73] evaluated
unsupervised methods such as Hidden Markov Models and GMMs for finding cell cycle
stages in human tissue culture cells indicating a fluorescent chromatin marker. Kurita
et al. [41] performed a combination of profiles extracted from High Content Screening
and untargeted metabolomics analysis to recognize modes of action of natural product
extracts.
Another useful application of unsupervised algorithms is visualizing or exploring
high dimensional datasets.
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Chapter 3
Methodology
This thesis focuses on the challenge of using information content that is as high as
possible, by considering cell populations and per-cell information to provide a system
for High Content Analysis.
Recently, deep learning methods have been applied with success in a variety of
applications [30, 5, 21, 54, 15, 16]. Moreover, deep learning algorithms can be fed with
raw data and find important representations automatically for detection or classifica-
tion. It has proven to be a very helpful tool for discovering complicated structures in
high-dimensional data and thus is helpful for various fields of science and business.
In this work, we developed five deep learning algorithms to predict MOAs based
on phenotypic screens of a population of cells in each image and single cells separately.
We demonstrated that our models can predict the MOA for a compendium of drugs
that modify cells without any segmentation and feature extraction steps. Previous
works have only used a small subset (15%) of the BBBC021 dataset as training and
test datasets. We believe that using this small volume dataset can lead to overfitting.
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Most of Object recognition tasks generally involve a single centered object per
image and current deep learning algorithms have not been applied to images with
multiple objects such as microscopy images with a number of cells. Moreover, cell
images have different characteristics; while objects seem in a constant scale and po-
sition, they are noisy and dimly lit. In this work, we provide five models inspired
from AlexNet [40], VGG [58], and GoogleNet [64] deep neural network algorithms
without using segmentation and feature extraction modules for single and multiple
object recognition in High Content Screening images as a case study. Moreover, the
proposed models predict the mechanism of actions for a compendium of drugs that al-
ter cells by using all features in DNA, F-actin, and B-tubulin channels. Furthermore,
these models predict the MOAs without a need for single cell identification.
Most of the current methods use CellProfiler software [11] for preprocessing and
segmenting cell images and rely on hand-tuned detection and feature extraction for
each cells image [39]. Our models can predict the MOA for a compendium of drugs
that alter cells without using CellProfiler software and any segmentation and feature
extraction steps, which is a significant improvement of traditional methods. These
models trained on a big High Content Screening dataset (MCF-7 breast cancer cells -
BBBC021), available from the Broad Bioimage Benchmark Collection [48], to predict
the mechanisms of action for a compendium of drugs and achieved the best results
ever reported on this dataset. Moreover, we found some hidden and unknown aspects
of this dataset. After visualizing the dataset through PCA and t-SNE algorithms,
we realized this dataset is imbalanced. In order to balance the BBBC021 dataset,
Random Undersampling, Random Oversampling, and SMOTE algorithms were used
[13] .
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We demonstrated that if the architecture and selection of parameters of the deep
learning models are configured properly, we do not need to use multiple instance
learning [39] for classifying cells or predicting MOAs. On the other hand, recent
research indicates that deep learning algorithms can learn features directly from the
data [28, 43, 63]. In this work, deep learning algorithms are applied to predict MOAs
from cell images directly. These models enable faster MOA prediction than the classi-
cal methods with image segmentation and feature extraction. Moreover, they perform
better without human handcrafted features in comparison to traditional methods.
Most of the profiling methods were evaluated on scales at the resolution of single
cells. The previous works usually did not work on a population of cells in a sample
and only worked on single cells separately in each sample. However, compound treat-
ments usually influence most cells in a sample (population of cells) and thus works
on single cells are inadequate to predict the MOAs in RNAi screens. Furthermore,
these models predict the MOAs without the need for single cell identification. This
work is presented as a strategy to evaluate the effect and safety of drug candidates
in complex biological systems. Our models are focused on morphology because there
is a wide diversity of subtle cellular responses in images as samples.
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3.1 Visualizing Data
Any data related challenge starts by exploring data itself. Our dataset has a high
number of dimensions. Therefore, visually exploring this dataset can help us see the
distributions of variables, classes, and correlations between them. Our work focuses
on applying two techniques for visualizing our data, namely, t-SNE (T-Distributed
Stochastic Neighbouring Entities) and a combination of PCA and t-SNE.
3.1.1 PCA (Principal Component Analysis)
PCA uses the correlation between some dimensions and provides a minimum number
of variables that keep the maximum amount of information [52, 34, 33, 56].
3.1.2 t-SNE(T-Distributed Stochastic Neighbouring Entities)
In this section, a short introduction to t-SNE [50] is described. t-SNE presents overall
similarities between data points in the high-dimensional space as a symmetric joint
probability distribution P . In addition a joint probability distribution Q is achieved
that defines the similarity in the low-dimensional space. t-SNE tries to find the best
representation Q in the low dimensional space that represents P . In order to find this
representation the positions in the low-dimensional space are optimized to minimize
the Kullback-Leibler(KL) divergence between the probability distribution P and Q
as a cost function C.
C(P,Q) = KL(P ||Q) =
N∑
i=1
N∑
j=1,j 6=i
pijln(
pij
qij
) (3.1)
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Maaten and Hinton [50] describe the working of t-SNE as: ”t-Distributed stochastic
neighbor embedding (t-SNE) minimizes the divergence between two distributions: a
distribution that measures pairwise similarities of the input objects and a distribution
that measures pairwise similarities of the corresponding low-dimensional points in the
embedding”.
3.2 Balancing Data
In most of the public datasets that are available the sample classes were balanced.
In other words, the number of samples of each class was approximately the same.
Researchers usually use cleaned up datasets in order to focus on specific algorithms
without considering other issues. Usually, samples are presented similar to Figure 3.1
in which points and colors of points indicate samples and their classes respectively.
The main goal of a supervised machine learning algorithm is to learn a separator
to recognize the two classes. You can see some decision boundaries using a variety of
machine learning algorithms as separators in Figure 3.2. Machine learning algorithms
are usually less sensitive to discovering the minority class and more sensitive to the
majority class thus our main goal is balancing the dataset before feeding them into
a machine learning algorithm. In many cases, if we do not balance the dataset, the
classifier output would be biased. When we visualize real datasets, one of the first
points we see is that they are imbalanced and noisier in comparison to more frequently
datasets. The distribution of real data usually looks like the Figure 3.3.
In real problems, datasets can be imbalanced more. Most fraud detection datasets
are strongly imbalanced. For example, around 2% of credit card accounts are scammed
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Figure 3.1: Balanced dataset.
Figure 3.2: Using some machine learning algorithms as separators.
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Figure 3.3: The classes are imbalanced.
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each year. Fault rates for factory products usually are about 0.1%. In these types of
problems, machine learning algorithms are applied to learn a large number of nega-
tive samples and a small number of positive samples. Traditional machine learning
algorithms usually are biased when encountering such problems because their loss
functions try to minimize error rate based on majority classes not minority classes.
Machine learning algorithms ignore minority samples in the worst situations. There
are some ways for balancing the dataset, such as oversampling the minority class, un-
dersampling the majority class, synthesizing new minority classes, SMOTE algorithm,
Removing minority samples, and switch to an Anomaly Detection frame.
3.2.1 Oversampling and Undersampling Methods
The easiest method for solving problems with imbalanced data is adjusting the dataset
until it is balanced. The Random Undersampling method removes some samples from
the majority class randomly. The random over sampling method replicates minority
samples to increase the number of samples in the minority class [13] (Figure 3.4).
Some machine learning scientists believe that Oversampling is better than Under-
sampling since it produces more data while Undersampling drops data. Repeating
data decreases the variance of variables in the dataset.
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Figure 3.4: Oversampling and Undersampling Methods
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3.2.2 SMOTE Algorithm
One of the best algorithms for Oversampling is the SMOTE (Synthetic Minority
Over-sampling Technique) method that, instead of repeating samples, produces new
samples through interpolations of the minority class and uses Undersampling on the
majority class [13]. Because of all of the abovementioned reasons in section 3.2.1, we
used the SMOTE algorithm that does not use re-sampling of samples but synthesizes
new ones. This method produces new minority samples by interpolating between
existing samples. Working by interpolating between minority samples is the main
limitation of the SMOTE algorithm because can not produce new exterior regions of
minority samples while it can only fill in the convex hull of minority samples in the
dataset (Figure 3.5).
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Figure 3.5: SMOTE Algorithm [13].
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3.3 Models
3.3.1 A model inspired by AlexNet
Our first model was inspired from AlexNet[40]. AlexNet was the first deep learning
model to win the Imagenet Challenge in 2012. The network has a very similar ar-
chitecture as LeNet [44] by Yann LeCun but the number of weights is much greater
and the shapes change from layer to layer because it is deeper with more filters per
layer and different convolutional layers (11*11, 5*5, 3*3 convolutions). We added
dropout in the input layer and two last convolutional layers before the final layer to
avoid overfitting. We converted the three last fully connected layers in the original
AlexNet to the convolutional layers before going to the output. The probability that
activations are kept in the dropout in the input layer and two last convolutional layers
before the final layer are supposed to be 0.8 and 0.5 respectively during training and
1.0 during testing. Our model has eight convolutional layers. There are 64 to 4096
filters within each convolutional layer and the filter size ranges from 1*1 to 11*11. A
single image (from the DNA or F-actin, or B-tubulin stain channels) is used as an
input in the input layer. ReLU activation functions are used after every convolutional
layer. Max pooling of 3*3 with stride 2 is applied to the outputs of layers 1, 2 and
5. In order to decrease computation, a stride of 4 is considered at the input layer of
the model. The original AlexNet used LRN in layers 1 and 2 before the max pooling.
LRN is not being used anymore as a favorite component in other convolutional neu-
ral networks thus the LRN layers are removed in our model and the initializers were
changed from random-normal-initializer to xavier-initializer. The basic architecture
is shown in Figure 3.6. The number of filters in the first convolution is 64 and the
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filter size 11*11 and the strides of the convolution along the height and width equals
4.
 
 
Input(224×224 grayscale image) 
Dropout on input layer 
conv1: number of filters=64, filter size=11×11, stride=4 
maxpool1:  filter size=3×3, stride=2 
conv2: number of filters=192, filter size=5×5 
maxpool2:  filter size=3×3, stride=2 
conv3: number of filters=384, filter size=3×3 
conv4: number of filters=384, filter size=3×3 
conv5: number of filters=256, filter size=3×3 
maxpool5:  filter size=3×3, stride=2 
conv6: number of filters=4096, filter size=5×5 
Dropout 
conv7: number of filters=4096, filter size=1×1 
Dropout 
conv8: number of filters=12(number of classes), filter size=1×1 
Flatten (We Flatten the output of previous layer while 
maintaining the batch size. A flattened tensor with shape 
[batch size, k].) 
output = soft-max 
Figure 3.6: Our model inspired by AlexNet
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3.3.2 Three models inspired by VGG
Our three other models were inspired from VGG-16 [58]. VGGNet was presented and
developed at the ILSVRC 2014 competition by Simonyan and Zisserman. VGGNet,
similar to AlexNet, only has 3*3 convolutions but lots of filters. Original VGG has two
different models: VGG-16 (described here) and VGG-19. In this work we developed
the modified versions of VGG, including VGG with 11 layers, VGG with 16 layers,
and VGG with 19 layers.
VGG is deeper in comparison to the previous model (AlexNet based model). The
larger filters (e.g. 5*5) are made from multiple smaller filters (e.g. 3*3), which have
fewer weights to reach the identical receptive fields for balancing out the cost of
moving deeper. Moreover, all the convolutional layers have the similar filter size of
3*3.
VGG is a modification of AlexNet that instead of having a lot of hyperparameters
has a simpler network. It focuses on having only these blocks:
convolutional layer = 3 * 3 filter, stride = 1, same
Max-Pool = 2 * 2 , stride = 2
Our architectures are shown in Figure 3.7. VGG-16 has around 138 million parameters
and most of the parameters are in the fully connected layers, which can be a bit
challenging to handle. It uses a total memory of 96MB per image for only forward
propagation. The VGG uses the most memory in the earlier layers. The number of
filters increases from 64 to 128 to 256 to 512. 512 was repeated twice. Pooling is
the only one component that is responsible for shrinking the dimensions. There is
another version of VGGNet called VGG-19 which is a bigger version.
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For decreasing the number of parameters we converted the fully connected layers
to convolutional layers. VGG does not use many hyper parameters therefore it is a
simpler model. It applies 3*3 filters with the stride of 1 in convolution layers and
SAME padding in pooling layers 2*2 with the stride of 2. The weight decay parameter
(L2 regularization coefficient) was supposed to be 0.0005.
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 VGG-11 (Inspired by VGG-16) Inspired by VGG-16 Inspired by VGG-19 
Input(224×224 grayscale image from F-actin or β-tubulin or DNA channels) 
Dropout on input layer 
conv1: number of filters=64, filter size=3×3 conv1: number of filters=64, filter size=3×3 conv1: number of filters=64, filter size=3×3 
 conv2: number of filters=64, filter size=3×3 conv2: number of filters=64, filter size=3×3 
maxpool1:  filter size=2×2 maxpool2:  filter size=2×2 maxpool2:  filter size=2×2 
conv2: number of filters=128, filter size=3×3 conv3: number of filters=128, filter size=3×3 conv3: number of filters=128, filter 
size=3×3 
 conv4: number of filters=128, filter size=3×3 conv4: number of filters=128, filter 
size=3×3 
maxpool2:  filter size=2×2 maxpool4:  filter size=2×2 maxpool4:  filter size=2×2 
conv3: number of filters=256, filter size=3×3 conv5: number of filters=256, filter size=3×3 conv5: number of filters=256, filter 
size=3×3 
conv3: number of filters=256, filter size=3×3 conv6: number of filters=256, filter size=3×3 conv6: number of filters=256, filter 
size=3×3 
 conv7: number of filters=256, filter size=3×3 conv7: number of filters=256, filter 
size=3×3 
  conv8: number of filters=256, filter 
size=3×3 
maxpool4:  filter size=2×2 maxpool7:  filter size=2×2 maxpool8:  filter size=2×2 
conv5: number of filters=512, filter size=3×3 conv8: number of filters=512, filter size=3×3 conv9: number of filters=512, filter 
size=3×3 
conv5: number of filters=512, filter size=3×3 conv9: number of filters=512, filter size=3×3 conv10: number of filters=512, filter 
size=3×3 
 conv10: number of filters=512, filter 
size=3×3 
conv11: number of filters=512, filter 
size=3×3 
  conv12: number of filters=512, filter 
size=3×3 
maxpool6:  filter size=2×2 maxpool10:  filter size=2×2 maxpool12:  filter size=2×2 
conv7: number of filters=512, filter size=3×3 conv11: number of filters=512, filter 
size=3×3 
conv13: number of filters=512, filter 
size=3×3 
conv7: number of filters=512, filter size=3×3 conv12: number of filters=512, filter 
size=3×3 
conv14: number of filters=512, filter 
size=3×3 
 conv13: number of filters=512, filter 
size=3×3 
conv15: number of filters=512, filter 
size=3×3 
  conv16: number of filters=512, filter 
size=3×3 
maxpool8:  filter size=2×2 maxpool13:  filter size=2×2 maxpool16:  filter size=2×2 
conv9: number of filters=4096, filter 
size=7×7 
conv14: number of filters=4096, filter 
size=7×7 
conv17: number of filters=4096, filter 
size=7×7 
Dropout 
conv10: number of filters=4096, filter 
size=1×1 
conv15: number of filters=4096, filter 
size=1×1 
conv18: number of filters=4096, filter 
size=1×1 
Dropout 
conv11: number of filters=12(number of 
classes), filter size=1×1 
conv16: number of filters=12(number of 
classes), filter size=1×1 
conv19: number of filters=12(number of 
classes), filter size=1×1 
Flatten (We Flatten the output of previous layer while maintaining the batch size. A flattened tensor with shape [batch size, k].) 
output = soft-max 
Figure 3.7: Our new models inspired by original VGG-16: new VGG-11, new VGG-
16, new VGG-19.
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3.3.3 A model inspired by GoogleNet
GoogleNet (Inception V1) from Google was the winner of the ILSVRC 2014 competition[64].
GoogleNet is a deeper convolutional neural network with 22 layers (Figure 3.8). It
has an Inception module that is made of parallel connections (Figure 3.9).
Each parallel connection uses various filters sizes (1*1, 3*3, 5*5) and 3*3 max-
pooling and we concatenate their outputs eventually for the module output. GoogleNet
has the impact of processing the input at different scales and then collect them so
that the next level can get compressed features from various scales simultaneously
because of using multiple filter sizes. 1*1 filters were used as bottleneck layers because
of decreasing the number of channels and eventually the number of weights.
The 22 layers include three convolutional layers, 9 Inception layers (each of which
is two convolutional layers), and one final convolutional layer (Figure 3.8). The output
of the final layer was flattened while it produced a flattened tensor with shape [batch
size, k]. After that, a Softmax function was applied.
The Inception modules outputs are constrained to change because these modules
are stacked on top of each other thus their spatial concentration is decreased(Figure 3.9).
The architecture of this model consists of stacked Inception modules with max-pooling
layers with stride 2. Although the original paper did not use batch normalization we
found it beneficial. We used batch normalization in our model but we did not show
it in the diagram (Figure 3.8).
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Figure 3.8: GoogleNet overall view [64]. Batch normalization was not shown in this
diagram.
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Figure 3.9: Inception module with bottleneck layers [64].
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Chapter 4
Experimental design and results
Recent works on analyzing High Content Screening images are focused on using
gained features from CellProfiler software. Our models can predict the MOA for
a compendium of drugs that alter cells, without using CellProfiler software and any
segmentation and feature extraction steps which would imply a significant improve-
ment on traditional methods. These findings were tested on the most popular High
Content Screening big dataset, BBBC021 [10]. Deep learning algorithms have usually
been tested on high quality datasets such as Imagenet, Cifar, etc., and their perfor-
mance on challenging datasets, including low quality samples, is rarely tested (e.g.
High Content Screening images with low quality). In this work we tested our models
on a High Content Screening breast cancer big dataset (MFC-7) as a case study. This
study tests the ability of deep learning algorithms on samples with very low qualities.
It is shown that deep learning algorithms can produce incredible results for predicting
MOAs on low quality images without using any segmentation and feature extraction
phases if their architectures and parameters are configured appropriately.
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In this work, we investigate the effect of deep learning algorithms on the predic-
tion of MOAs. We proposed five models for the prediction of MOAs from the MFC-7
(BBBC021) dataset into 12 MOAs. All previous works focused on single cell identi-
fication. We believe that single cell recognition is not the most useful for predicting
MOAs because compound treatments usually impact most cells in a sample in a va-
riety of ways, not just a single cell. Therefore, we worked on a population of cells in
samples to predict MOAs in RNAi screens. We believe that not only can our models
predict a specific phenotype through a population of cells in a particular sample but
they also can predict specific phenomenon by the low proportion of cells in a sample.
We think there are some relations between cells in a channel image that have not
been considered. Object recognition tasks generally have a single centered object
per image. Current deep learning algorithms have not been applied to images that
include multiple specific complex objects such as microscopy images because there
are a number of objects (cells) in these images.
4.1 Data
We used dataset BBBC021 [10] concerning molecular cancer therapeutics (MCF-7
wild-type P53 breast cancer cells) available from the Broad Bioimage Benchmark
Collection [48]. A comprehensive study has not been performed on the BBBC021
dataset. The images were treated for 24 h with a collection of 113 molecules at eight
concentrations. The ground-truth data set includes the mechanisms of action of 103
compound-concentrations (38 compounds at 1-7 concentrations each) [48]. For all 103
treatments, some compounds were active at up to seven concentrations, and some at
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only one concentration, covering 12 mechanisms of action classes (Figure 4.1). All 103
treatments were classified into MOAs by assigning to the predicted class of each its
most similar MOA. The cells were imaged by fluorescent microscopy, and labeled for
DNA, F-actin, and B-tubulin. For example, DNA, F-actin, and B-tubulin channels
for DNA damage MOA are shown in Figures 4.2, 4.3, and 4.4, where the compound
is mitomycin C and the concentration is 0.3 at week 4. There are 39600 image files,
(13200 views in three channels), in TIFF format (16 bit). All the images have been
converted to grayscale images (8 bit images). The original images are all 1280 by
1024 pixels. These images were converted to 224 by 224 pixels grayscale images to
feed our machine learning models. Therefore each image has 224*224 dimensions,
and each one holds the gray level of one specific pixel.
On deep learning projects, usually the first crucial step is to engage with a large
amount of data or a large number of images (e.g. a couple of million images in
ImageNet). In such a case, it is inefficient to load every single image from the hard
disk separately, use image preprocessing, and pass the image to the deep learning
algorithm to train or test. Preprocessing requires time, and reading multiple images
from a hard disk is more time consuming than having them all in a single file and
reading them as a single bunch of data. Luckily, there are different useful data models
and libraries, and one that we are interested in using for this project is called HDF5.
In this work, we saved a large number of images in a single HDF5 file and then loaded
them from the file as a single batch. It is not important how large the dataset, nor
whether it is larger than our memory size or not. HDF5 produces tools to manage,
manipulate, compress, and save the data.
The dataset includes 39600 images, including 13200 field-of-view images in three
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channels (DNA, F-actin, and B-tubulin channels). This is a large dataset, but some
samples are unlabeled and some are artificial (DMSO samples). The dominance of
positive bias in the mock-treatments (DMSO) suggests that the accuracy of the true
treatments may also be overestimated. Therefore, the unlabeled and DMSO samples
were removed from the dataset. The number of samples for all classes after removing
unlabeled and DMSO samples is 7584. We divided this dataset into two parts: first,
6444 samples of DNA, B-tubulin, and F-actin channels as training data, and second,
1140 samples of DNA, B-tubulin, and F-actin channels as testing data. Each image in
our dataset (DNA, actin filaments, or B-tubulin) has a corresponding label, a number
between 0 and 11, representing the MOA (Table 4.1).
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Figure 4.1: The ground-truth set [10].
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Table 4.1: Mechanism of actions
Mechanism of action Code of class
Actin disruptors 0
Aurora kinase inhibitors 1
Cholesterol-lowering 2
DNA damage 3
DNA replication 4
Eg5 inhibitors 5
Epithelial 6
Kinase inhibitors 7
Microtubule destabilizers 8
Microtubule stabilizers 9
Protein degradation 10
Protein synthesis 11
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Figure 4.2: DNA channel image for DNA damage MOA when the compound is mit-
omycin C and concentration is 0.3 in week 4 [10].
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Figure 4.3: B-Tubulin channel image for DNA damage MOA when the compound is
mitomycin C and concentration is 0.3 in week 4 [10].
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Figure 4.4: Actin channel image for DNA damage MOA when the compound is
mitomycin C and concentration is 0.3 in week 4 [10].
4.2 Visualizing the Data
Any data related challenge starts by exploring data itself. The BBBC021 dataset has
a large number of variables and a high number of dimensions. Therefore, visually
exploring this dataset can help us see the distributions of variables, classes, and
correlations between them. In this work, we focus on applying two techniques for
visualizing the data. We visualized the original imbalanced data and balanced data
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through two methods, namely, t-SNE and a combination of PCA and t-SNE. We want
to reduce the number of dimensions for visualizing the dataset while trying to keep
as much of the variation in the data as possible.
4.2.1 PCA
The PCA method is used for dimensionality reduction in the dataset while keeping
as much of the information as possible regarding how the data is distributed.
4.2.2 t-SNE
One of the most popular methods for dimensionality reduction and visualizing high
dimensional datasets is t-SNE (t-Distributed Stochastic Neighbor Embedding). In
comparison to PCA, this method is a probabilistic algorithm. This method looks at
the original data as an input to the algorithm and finds the representation of the data
with fewer dimensions using matching both distributions (original data and lower-
dimensional data). Moreover, this method compares the original data to the lower-
dimensional data and then finds the closest approximation of the lower-dimensional
data to the original data. The serious disadvantage of this method is that it is
computationally laborious. In cases of very high dimensional data, this limitation may
be addressed by using another dimensionality reduction algorithm before applying t-
SNE. For example, PCA can be used for dense data or Truncated SVD can be used
for sparse data. There is a significant improvement in comparison to the t-SNE
visualization we used previously, without PCA. As you can see in figure 4.6, the High
Content Screening samples are very clearly clustered in their own class. If we then
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use a clustering algorithm to identify the separate clusters, we could probably assign
new points to a label with a high degree of accuracy.
On the other hand, according to the notes before, the number of dimensions was
reduced by PCA before feeding the data into the t-SNE algorithm. Subjecting raw
data to the PCA algorithm produced a new dataset with 40 dimensions, and this
was fed into the t-SNE algorithm (Figure 4.6). A scatter-plot of the first to 40th
principal components that fed to t-SNE is created and the different types of classes
(MOAs) identified by colour are shown in Figure 4.6. It is obvious that, some types of
MOAs are clustered together in groups which means that the first to fortieth principal
components and t-SNE are enough to visualize the specific types of MOAs.
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Figure 4.5: The original dataset was visualized through t-SNE algorithm. The di-
mensions colored by the code of classes(MOAs).
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Figure 4.6: The original dataset was visualized through PCA + t-SNE algorithms.
The dimensions colored by the code of classes(MOAs).
4.3 Producing Balanced Dataset
After visualizing and looking at the dataset carefully, it is obvious that the BBBC021
labeled dataset is highly unbalanced (Figures 4.5 and 4.6). Visualizing the data
shows that there are a majority of samples in Microtubule stabilizers class (class
9) in comparison to the number of samples for other classes. We used three algo-
rithms to balance the dataset, namely, Undersampling, Oversampling, and SMOTE
[13]. Researchers have not considered the impact of imbalanced data on deep learn-
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ing algorithms. Therefore, in this work, we investigate the impact of data on the
performance of deep learning algorithms. A balanced dataset produced by the Un-
dersampling method was visualized through the t-SNE (Figure 4.7) and PCA+t-SNE
(Figure 4.8) algorithms.
Figure 4.7: The balanced dataset was visualized through t-SNE after balancing the
data by Undersampling. The dimensions are colored according to their class code
(MOA).
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Figure 4.8: The balanced dataset was visualized through PCA + t-SNE algorithms
after balancing data by Undersampling method. The dimensions colored by the code
of classes (MOAs).
After using the Undersampling method as a balancing the data method, the num-
ber of samples is 1440. We selected 85% of the samples (images) from 103 treatments
to train (1224 samples with one of the three channels namely, F-actin, B-tubulin,
and DNA) and 15% (216 samples) to test the models.From Figures 4.7 and 4.8, it is
clear that all the samples are positioned apart nicely and grouped together with their
specific class. The number of samples after using the Oversampling SMOTE method
is 51408 , 85% and 15% of these samples were taken from the training and testing
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datasets, respectively. Concerning the Oversampling method, we reused samples in
the minority class repeatedly, and then we feed them into our models. At this step,
there will be replication. Thus, the train and test sets include the same samples.
This can cause overfitting. They are made and shuﬄed by considering preserving the
percentage of samples for each class.
4.4 Models Testing
The proposed models require a fixed input of dimensionality. Thus, the images were
down-sampled to a constant resolution of 224*224 pixels. We only subtracted the
mean and divided by the standard deviation of each channel in our training set as
an image pre-processing step. Our models were trained on the raw gray level values
of the pixels from the DNA, F-actin, and B-tubulin channels for each mechanism of
action.
According to the results, our models can predict specific phenotypes through the
population of cells in a particular sample. Our best model (inspired by GoogleNet and
using SMOTE algorithm) achieved 86% accuracy on all samples with a population
of cells in the large BBBC021 dataset without requiring segmentation or a feature
extraction step. Moreover, in comparison to the previous works, our model reached
98% accuracy on a single cell for predicting MOAs. Our results show that five models,
inspired by GoogleNet, AlexNet, and VGG are capable of recognizing multiple objects
(cells) in images. These algorithms were tested three times and an accuracy average
over these three replications was calculated. We determined the accuracy, top-2
error, top-3 error, confusion matrix, and normalized confusion matrix as objective
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measures for estimating discriminatory ability. Moreover, our models can classify
those MOAs that are difficult to classify with the human visual system. With SMOTE
and GoogleNet, the prediction accuracy was 86% which is significantly better than
any of the other models that were tested (table 4.6).
Keskar et al. [38] points out that having a very large batch size can reduce the
generalization ability of the machine learning algorithm thus we supposed the batch
size 16. Our models were tested on full images. We did not use any preprocessing
process except mean subtraction and division by the standard deviation. The full
images were resized to feed the models. We suppose each grayscale stain image is
related to one of the 12 MOAs. Moreover, each sample can be relevant to one of the
three channels including DNA, F-actin, and B-tubulin.
We trained our models with Stochastic Gradient Descent for 500 epochs with an
initial learning rate of 0.001. At first, we used a fixed learning rate (0.001) for all
layers, which we adjusted manually throughout training. Then Steepest Gradient
Descent optimizer was used with adaptive learning rate. The results with adap-
tive learning rate show improvement in comparison to fixed learning rate during the
training phase (Figures 4.9 and 4.10). We used the adaptive learning rate method as
follows.
• The initial learning rate is 0.001
• decay = learning rate / total steps
• learning rate = learning rate ∗1/(1 + decay ∗ i).
As shown in Figures 4.30, 4.32, 4.34, 4.36, 4.38, more than 95% of the error
on predicting MOAs comes from protein degradation and protein synthesis classes
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Figure 4.10: Adaptive learning rate and loss function
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(SMOTE + our deep learning models is section 4.4.2). Average accuracy on all of
the batches for each epoch was obtained as reported in Figure 4.25. Predicted ac-
curacy was obtained by taking the average over three experimental replicates. Our
VGG-11, VGG-16, GoogleNet, AlexNet models combined with SMOTE algorithm
achieved 100% accuracy for predicting Actin disruptors, Aurora kinase inhibitors,
Cholesterol-lowering, DNA damage, DNA replication, Eg5 inhibitors, Epithelial, Ki-
nase inhibitors, Microtubule stabilizer, and Protein synthesis MOAs (normalized con-
fusion matrices in Figures 4.30, 4.32, 4.34, 4.36). It is notable that our models mainly
obtain their discriminatory capability from a combination of image features. The top-
3 and top-2 errors also achieved to describe the accuracy of our algorithms (Figures
4.13, 4.14, 4.27, 4.28, 4.41, 4.42).
The similarity level of MOAs are shown in normalized confusion matrices in sec-
tions 4.4.1, 4.4.2, and 4.4.3. The confusion matrix is applied to evaluate the quality of
the output of our models. The confusion matrix with and without normalization are
shown in Figures in sections 4.4.1, 4.4.2, and 4.4.3. The diagonal elements represent
the number of samples that predicted correctly in each class.
The under-sampled dataset could not provide satisfactory results because of the
low number of samples while the results for combining over-sampling SMOTE method
and deep learning algorithms are very satisfactory because it deals with many samples.
Moreover, the sensitivity of our models will be increased by Undersampling. As shown
in section 4.4.3 the results are very poor because our models were trained using a few
samples. On the other hand, using the Oversampling method before feeding the data
into classifier can produce overfitting problems.
Moreover, SMOTE algorithm effectively tries to solve the generalization problem
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for minority class. Results are very satisfactory now. Especially for GoogleNet, we
obtained accuracy 86% with the SMOTE algorithm (on all samples in the dataset).
By using SMOTE algorithm before our models, we obtained almost perfect accuracy.
As expected, more data solved the problem regardless of using SMOTE algorithm
as a smart Oversampling method. According to the results, SMOTE Oversampling
algorithm properly is much better than Undersampling, for this dataset.
Our GoogleNet, AlexNet, and VGG-11 models achieved very good top-3 error
(0.03) for all 12 MOA classes. Moreover, our VGG-16 and VGG-19 models reached
0.04 and 0.05 top-3 error respectively. Combination of SMOTE and our deep learning
models take 80 hours to train on two Nvidia GPUs with 16 cores and 128 Gigabytes
memory.
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4.4.1 Our Deep Learning algorithms on imbalanced data
Table 4.2 shows the number of samples in the imbalanced raw dataset, the train,
and test datasets. According to the results, many protein degradation and protein
synthesis are misclassified as microtubule stabilizers MOA when imbalanced data and
our deep learning algorithms including GoogleNet or VGG-11 are combined.
Many MOAs are misclassified as microtubule stabilizers when our models includ-
ing AlexNet, VGG-16, and VGG-19 are applied on imbalanced data directly because
the number of microtubule stabilizers samples is high in comparison to the other
MOAs in our dataset.
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Figure 4.11: Accuracy on the training and test datasets (our deep learning models
on the imbalanced data)
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Table 4.2: The number of samples in the imbalanced raw dataset is 7584. The number
of samples in the train dataset is 6446. The number of samples in the test dataset is
1138.
MOA (raw dataset) Code of class Number of samples
train dataset test dataset
Actin disruptors 0 153 27
Aurora kinase inhibitors 1 367 65
Cholesterol-lowering 2 184 32
DNA damage 3 275 49
DNA replication 4 245 43
Eg5 inhibitors 5 367 65
Epithelial 6 225 39
Kinase inhibitors 7 102 18
Microtubule destabilizers 8 428 76
Microtubule stabilizers 9 3641 643
Protein degradation 10 214 38
Protein synthesis 11 245 43
Table 4.3: The accuracy on the imbalanced test dataset.
Our models inspired by
GoogleNet AlexNet VGG-16 (VGG-11) VGG-16 VGG-19
Accuracy 74% 56% 66% 56% 56%
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Table 4.4: The top-2 and top-3 errors on the imbalanced test dataset.
Our models inspired by
GoogleNet AlexNet VGG-16 (VGG-11) VGG-16 VGG-19
Top-2 error 0.14 0.37 0.27 0.36 0.37
Top-3 error 0.07 0.29 0.21 0.31 0.29
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Figure 4.12: Training loss (our deep learning models on the imbalanced data)
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Figure 4.13: top-3 error on the imbalanced dataset
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Figure 4.14: top-2 error on the imbalanced dataset
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Figure 4.15: confusion matrix, our GoogleNet, imbalanced dataset.
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Figure 4.16: normalized confusion matrix, our GoogleNet, imbalanced dataset.
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Figure 4.17: confusion matrix, our AlexNet, imbalanced dataset
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Figure 4.18: normalized confusion matrix, our AlexNet, imbalanced dataset.
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Figure 4.19: confusion matrix, our VGG-11, imbalanced dataset.
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Figure 4.20: normalized confusion matrix, our VGG-11, imbalanced dataset.
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Figure 4.21: confusion matrix, our VGG-16, imbalanced dataset
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Figure 4.22: normalized confusion matrix, our VGG-16, imbalanced dataset.
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Figure 4.23: confusion matrix, our VGG-19, imbalanced dataset
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Figure 4.24: normalized confusion matrix, our VGG-19, imbalanced dataset.
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4.4.2 Combination of our Deep Learning models and SMOTE
algorithm
Table 4.5 shows the number of samples in the balanced dataset, train dataset, and
test dataset by using SMOTE algorithm. Based on the results in Figures 4.25 to 4.38,
Tables 4.6, and 4.7, many protein degradation and protein synthesis were misclassified
as microtubule stabilizers MOA when SMOTE and our models including GoogleNet
or VGG-11 or VGG-16 were combined. Moreover, many microtubule stabilizers and
protein degradation were still misclassified as protein synthesis when SMOTE and
AlexNet were combined. Many microtubule stabilizers and protein synthesis were
misclassified as protein degradation when SMOTE and VGG-19 were combined (Fig-
ure 4.38).
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Figure 4.25: Accuracy on the training and test datasets (combination of the deep
learning models and SMOTE algorithm on the imbalanced data)
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Table 4.5: The number of samples in the balanced dataset by SMOTE is 51408. The
number of samples in the train dataset is 43696. The number of samples in the test
dataset is 7712.
MOA (balanced dataset-SMOTE) Code of class Number of samples
train dataset test dataset
Actin disruptors 0 3641 643
Aurora kinase inhibitors 1 3641 643
Cholesterol-lowering 2 3642 642
DNA damage 3 3641 643
DNA replication 4 3642 642
Eg5 inhibitors 5 3641 643
Epithelial 6 3641 643
Kinase inhibitors 7 3642 642
Microtubule destabilizers 8 3641 643
Microtubule stabilizers 9 3641 643
Protein degradation 10 3642 642
Protein synthesis 11 3641 643
Table 4.6: The accuracy on the balanced test dataset by using SMOTE.
Our models inspired by
GoogleNet AlexNet VGG-16 (VGG-11) VGG-16 VGG-19
Accuracy 86% 79% 80% 78% 76%
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Table 4.7: The top-2 and top-3 errors on the balanced test dataset by using SMOTE.
Our models inspired by
GoogleNet AlexNet VGG-16 (VGG-11) VGG-16 VGG-19
Top-2 error 0.11 0.12 0.12 0.12 0.13
Top-3 error 0.03 0.03 0.03 0.04 0.05
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Figure 4.26: Training loss (combination of the deep learning models and SMOTE
algorithm on the imbalanced data)
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Figure 4.27: top-3 error on the balanced dataset by using SMOTE
0 100 200 300 400 500
Epoch
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
to
p-
2 
er
ro
r
top-2 error (Combination of the deep learning models and SMOTE algorithm on imbalanced data)
top-2 error (Alexnet + SMOTE)
top-2 error (GoogleNet + SMOTE)
top-2 error (VGG-11 + SMOTE)
top-2 error (VGG-16 + SMOTE)
top-2 error (VGG-19 + SMOTE)
Figure 4.28: top-2 error by using SMOTE
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Figure 4.29: confusion matrix, our GoogleNet, SMOTE,balanced dataset.
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Figure 4.30: normalized confusion matrix, our GoogleNet,SMOTE,balanced dataset.
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Figure 4.31: confusion matrix, our AlexNet,SMOTE,balanced dataset.
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Figure 4.32: normalized confusion matrix, our AlexNet,SMOTE,balanced dataset.
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Figure 4.33: confusion matrix, our VGG-11,SMOTE,balanced dataset.
Ac
tin
 d
isr
up
to
rs
Au
ro
ra
 k
in
as
e 
in
hi
bi
to
rs
Ch
ol
es
te
ro
l-l
ow
er
in
g
DN
A 
da
m
ag
e
DN
A 
re
pl
ic
at
io
n
Eg
5 
in
hi
bi
to
rs
Ep
ith
el
ia
l
Ki
na
se
 in
hi
bi
to
rs
M
ic
ro
tu
bu
le
 d
es
ta
bi
liz
er
s
M
ic
ro
tu
bu
le
 s
ta
bi
liz
er
s
Pr
ot
ei
n 
de
gr
ad
at
io
n
Pr
ot
ei
n 
sy
nt
he
sis
Predicted label
accuracy=0.7942
Actin disruptors
Aurora kinase inhibitors
Cholesterol-lowering
DNA damage
DNA replication
Eg5 inhibitors
Epithelial
Kinase inhibitors
Microtubule destabilizers
Microtubule stabilizers
Protein degradation
Protein synthesis
Tr
u
e
 l
a
b
e
l
1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.55 0.44 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 0.00
Normalized confusion matrix
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
Figure 4.34: normalized confusion matrix, our VGG-11,SMOTE,balanced dataset.
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Figure 4.35: confusion matrix, our VGG-16,SMOTE,balanced dataset.
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Figure 4.36: normalized confusion matrix, our VGG-16,SMOTE,balanced dataset.
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Figure 4.37: confusion matrix, our VGG-19,SMOTE,balanced dataset.
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Figure 4.38: normalized confusion matrix, our VGG-19,SMOTE,balanced dataset.
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4.4.3 Combination of our Deep Learning models and Under-
sampling algorithm
The results are shown in Figures 4.39 to 4.52, Tables 4.9, and 4.10. Table 4.8 shows
the number of samples for each MOA class and the number of samples as train and
test samples in the balanced dataset by using Undersampling method. Many mi-
crotubule stabilizers and protein synthesis were misclassified as protein degradation
when Undersampling and our models including AlexNet, VGG-11, and VGG-16 were
combined (Figures 4.45, 4.46, 4.47, 4.48, 4.49, 4.50). Protein degradation and pro-
tein synthesis were misclassified as microtubule stabilizers when Undersampling and
GoogleNet were combined (Figures 4.43, 4.44).
Table 4.8: The number of samples in the balanced dataset by Undersampling method
is 1440. The number of samples in the train dataset is 1224. The number of samples
in the test dataset is 216.
MOA (balanced dataset-Undersampling) Number of samples
train dataset test dataset
For each MOA class 102 18
Table 4.9: The accuracy on balanced test dataset by using Undersampling method.
Our models inspired by
GoogleNet AlexNet VGG-16 (VGG-11) VGG-16 VGG-19
Accuracy 45% 31% 26% 18% 22%
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Table 4.10: The top-2 and top-3 errors on the balanced test dataset by using Under-
sampling method.
Our models inspired by
GoogleNet AlexNet VGG-16 (VGG-11) VGG-16 VGG-19
Top-2 error 0.33 0.5 0.5 0.63 0.58
Top-3 error 0.17 0.30 0.30 0.42 0.41
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Figure 4.39: Accuracy on the training and test datasets (combination of the deep
learning models and Undersampling algorithm on the imbalanced data)
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Figure 4.40: Training loss (combination of the deep learning models and Undersam-
pling algorithm on the imbalanced data)
73
0 100 200 300 400 500
Epoch
0.2
0.3
0.4
0.5
0.6
0.7
0.8
to
p-
3 
er
ro
r
top-3 error (Combination of the deep learning models and Undersampling algorithm on imbalanced data)
top-3 error (Alexnet + Undersampling)
top-3 error (GoogleNet + Undersampling)
top-3 error (VGG-11 + Undersampling)
top-3 error (VGG-16 + Undersampling)
top-3 error (VGG-19 + Undersampling)
Figure 4.41: top-3 error by using Undersampling.
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Figure 4.42: top-2 error by using Undersampling
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Figure 4.43: confusion matrix, our GoogleNet, Undersampling.
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Figure 4.44: normalized confusion matrix, our GoogleNet, Undersampling.
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Figure 4.45: confusion matrix, our AlexNet, Undersampling.
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Figure 4.46: normalized confusion matrix, our AlexNet, Undersampling.
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Figure 4.47: confusion matrix, our VGG-11, Undersampling.
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Figure 4.48: normalized confusion matrix, our VGG-11, Undersampling.
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Figure 4.49: confusion matrix, our VGG-16, Undersampling.
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Figure 4.50: normalized confusion matrix, our VGG-16, Undersampling.
78
Ac
tin
 d
isr
up
to
rs
Au
ro
ra
 k
in
as
e 
in
hi
bi
to
rs
Ch
ol
es
te
ro
l-l
ow
er
in
g
DN
A 
da
m
ag
e
DN
A 
re
pl
ic
at
io
n
Eg
5 
in
hi
bi
to
rs
Ep
ith
el
ia
l
Ki
na
se
 in
hi
bi
to
rs
M
ic
ro
tu
bu
le
 d
es
ta
bi
liz
er
s
M
ic
ro
tu
bu
le
 s
ta
bi
liz
er
s
Pr
ot
ei
n 
de
gr
ad
at
io
n
Pr
ot
ei
n 
sy
nt
he
sis
Predicted label
accuracy=0.1923
Actin disruptors
Aurora kinase inhibitors
Cholesterol-lowering
DNA damage
DNA replication
Eg5 inhibitors
Epithelial
Kinase inhibitors
Microtubule destabilizers
Microtubule stabilizers
Protein degradation
Protein synthesis
Tr
u
e
 l
a
b
e
l
1 0 15 0 0 0 0 1 0 0 0 0
3 0 11 0 0 0 0 4 0 0 0 0
0 0 13 0 0 0 0 2 0 0 0 0
0 0 17 0 0 0 0 1 0 0 0 0
0 0 10 0 0 0 0 5 0 0 0 2
0 0 12 0 0 0 0 4 0 0 0 2
1 0 7 0 0 0 0 6 0 0 0 1
0 0 9 0 0 0 0 8 0 0 0 1
0 0 9 0 0 0 0 2 0 0 0 7
0 0 0 0 0 0 0 0 0 0 0 18
0 0 0 0 0 0 0 0 0 0 0 18
0 0 0 0 0 0 0 0 0 0 0 18
Confusion matrix without normalization
0
2
4
6
8
10
12
14
16
18
Figure 4.51: confusion matrix, our VGG-19, Undersampling.
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0.07 0.00 0.47 0.00 0.00 0.00 0.00 0.40 0.00 0.00 0.00 0.07
0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.44 0.00 0.00 0.00 0.06
0.00 0.00 0.50 0.00 0.00 0.00 0.00 0.11 0.00 0.00 0.00 0.39
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.00
Normalized confusion matrix
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Figure 4.52: normalized confusion matrix, our VGG-19, Undersampling.
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4.5 Comparison with the Previous Works
Although our models were performed on a population of cells for predicting mecha-
nism of actions in drug discovery, our models also were applied on single cell identifi-
cation because of comparing our methodologies performance with the results of Ljosa
et al. [47], Kandaswamy et al. [36], Kraus et al. [39], Ando et al. [2], and Singh et al.
[60]. The previous works did not test their methods on raw images(gray scale images)
directly in contrast to our approaches. Ljosa et al. [47] used 453 features obtained
from applying CellProfiler software. Kandaswamy et al. [36] used the 453 features of
each cell, similar to the work of Ljosa [47] through CellProfiler software for a particu-
lar MOA class. Kraus et al. [39] also used CellProfiler software to get the segmented
cell images. In addition, they proposed a method for localizing cells with Jacobian
maps for detecting cells in the image. Ando et al. [2] demonstrated that the small
total variation PCA dimensions are important for identifying cellular phenotypes,
while the large total variation PCA dimensions are actually more representative of
nuisance variation. Moreover, Ando et al. [2], Ljosa et. al. [47], and Kandaswamy et
al. [36] did not take advantage of the automatic feature extraction property as one of
the most important features in deep learning while this most important characteristic
was used perfectly in our models.
In contrast to previous methods, our models outperformed previously published
results for MCF-7 breast cancer cells without any pre or post processing modules
except normalizing the images by subtracting the mean and dividing by the standard
deviation of each channel in our training set. Our results indicated that subtracting
the mean and dividing by the standard deviation process does not provide significant
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improvement in accuracy of our models.
In contrast to previous works, our models were tested on raw grayscale images
in the BBBC021 dataset. Previous works only used a small subset of the BBBC021
dataset as training and test datasets. Not only our models were tested on all true
labeled samples in BBBC021 dataset (as explained in previous sections), but also, in
order to compare with previous works, our models were tested on the same subset of
the BBBC021 dataset that Ljosa et al.[47], Kandaswamy et al.[36], Kraus et al.[39],
and Ando et al.[2] used. Thus we considered 15% of images from these 103 treat-
ments to train and validate our models. The similar proportion of the data reported
in previous works was applied to train our best model. We evaluated all the image
channels and reported the predicted accuracy across the treatments. According to
our experiments, we believe that using this small volume dataset without dropout can
lead to overfitting for all deep learning models. Thus, as noted in our methodology
section(chapter 3), dropout was the main element that we used in input and final lay-
ers for avoiding overfitting. In comparison to the previous works, our GoogleNet and
VGG-11 models combined with SMOTE method achieved better accuracy(99% ac-
curacy and 98% accuracy respectively in Table 4.11). The center of mass coordinates
of segmented cells were extracted and these coordinates were applied to crop single
cells from the full resolution images using CellProfiler. The crop size was supposed
to be 64*64 pixels.
Our model inspired by GoogleNet exceeds the newest accuracy with 99% NSC(Not-
Same-Compound) accuracy. The accuracy for 10 MOAs of the 12 MOAs is 100% with
the error in classifying protein degradation and protein synthesis MOAs (normalized
confusion matrices in Figures 4.30, 4.32, 4.34, 4.36).
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Table 4.11: Comparison with the previous works (Predicting MOAs based on a single
cell view.).
Method Accuracy
Ljosa et al. [47] (2013), traditional method 94%
Singh et al. [60] (2014), traditional method 90%
Kandaswamy et al.[36], (2016) 88%
Kraus et al.[39], (2016) 97%
Ando et al.[2], (2017) 96%
Our model (SMOTE + GoogleNet) 99%
Our model (SMOTE + VGG-11) 98%
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Chapter 5
Conclusions and Future Work
This work proposes a fully automated system using deep learning without human
interaction. We have shown that deep neural networks are capable of recognizing
MOAs from microscopy images if they were configured properly. The proposed mod-
els achieve higher accuracies than previous classical methods, requires less time and
expertise to recognize MOAs because image segmentation and feature extraction mod-
ules are eliminated. This work establishes the basis of High Content Screening systems
for future explorations.
This system does not need to use CellProfiler software for detecting and pre-
processing cell images. We actually deployed multi-object detection and recognition
automatically without using object detection, preprocessing and feature extraction
steps for predicting MOAs in drug discovery. Not only our deep learning models
worked on a population of cells very well for predicting MOAs but also they achieved
better accuracy in comparison to the previous works.
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